CNO FINANCIAL GROUP INC (CNO) Stock Fundamental Analysis
NYSE:CNO - New York Stock Exchange, Inc. - US12621E1038 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to CNO. CNO was compared to 143 industry peers in the Insurance industry. There are concerns on the financial health of CNO while its profitability can be described as average. CNO has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
CNO had positive earnings in the past year.
CNO had a positive operating cash flow in the past year.
Each year in the past 5 years CNO has been profitable.
Each year in the past 5 years CNO had a positive operating cash flow.
1.2 Ratios
CNO has a Return On Assets of 0.82%. This is comparable to the rest of the industry: CNO outperforms 40.56% of its industry peers.
CNO's Return On Equity of 12.07% is fine compared to the rest of the industry. CNO outperforms 60.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.82% | ||
| ROE | 12.07% | ||
| ROIC | N/A |
ROA(3y)1.25%
ROA(5y)1.24%
ROE(3y)21.43%
ROE(5y)16.13%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CNO's Profit Margin of 6.99% is in line compared to the rest of the industry. CNO outperforms 48.25% of its industry peers.
In the last couple of years the Profit Margin of CNO has declined.
CNO has a better Operating Margin (15.63%) than 72.73% of its industry peers.
In the last couple of years the Operating Margin of CNO has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.63% | ||
| PM (TTM) | 6.99% | ||
| GM | N/A |
OM growth 3Y-3.08%
OM growth 5Y9.46%
PM growth 3Y-13.73%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The number of shares outstanding for CNO has been reduced compared to 1 year ago.
CNO has less shares outstanding than it did 5 years ago.
CNO has a worse debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of CNO is 6.57, which is on the high side as it means it would take CNO, 6.57 years of fcf income to pay off all of its debts.
CNO has a worse Debt to FCF ratio (6.57) than 64.34% of its industry peers.
CNO has a Debt/Equity ratio of 1.74. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.74, CNO is not doing good in the industry: 90.21% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.74 | ||
| Debt/FCF | 6.57 | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.40% over the past year.
Measured over the past years, CNO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.49% on average per year.
Looking at the last year, CNO shows a small growth in Revenue. The Revenue has grown by 7.33% in the last year.
The Revenue has been growing slightly by 2.35% on average over the past years.
EPS 1Y (TTM)12.4%
EPS 3Y12.53%
EPS 5Y16.49%
EPS Q2Q%-17.14%
Revenue 1Y (TTM)7.33%
Revenue growth 3Y3.34%
Revenue growth 5Y2.35%
Sales Q2Q%5.4%
3.2 Future
The Earnings Per Share is expected to grow by 6.59% on average over the next years.
CNO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.66% yearly.
EPS Next Y-4.54%
EPS Next 2Y3.85%
EPS Next 3Y5.87%
EPS Next 5Y6.59%
Revenue Next Year3.4%
Revenue Next 2Y3.3%
Revenue Next 3Y3.23%
Revenue Next 5Y3.66%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.76, the valuation of CNO can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of CNO indicates a somewhat cheap valuation: CNO is cheaper than 71.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.24, CNO is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.30, the valuation of CNO can be described as reasonable.
Based on the Price/Forward Earnings ratio, CNO is valued a bit cheaper than 64.34% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CNO to the average of the S&P500 Index (36.42), we can say CNO is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.76 | ||
| Fwd PE | 8.3 |
4.2 Price Multiples
72.03% of the companies in the same industry are more expensive than CNO, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.19 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.53
EPS Next 2Y3.85%
EPS Next 3Y5.87%
5. Dividend
5.1 Amount
CNO has a Yearly Dividend Yield of 1.92%.
CNO's Dividend Yield is comparable with the industry average which is at 3.38.
Compared to the average S&P500 Dividend Yield of 2.40, CNO is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.92% |
5.2 History
On average, the dividend of CNO grows each year by 8.19%, which is quite nice.
CNO has been paying a dividend for at least 10 years, so it has a reliable track record.
CNO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.19%
Div Incr Years12
Div Non Decr Years12
5.3 Sustainability
22.04% of the earnings are spent on dividend by CNO. This is a low number and sustainable payout ratio.
CNO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP22.04%
EPS Next 2Y3.85%
EPS Next 3Y5.87%
NYSE:CNO (8/5/2025, 10:34:01 AM)
35.73
-0.11 (-0.31%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners97.39%
Inst Owner Change1.27%
Ins Owners2.28%
Ins Owner Change0.53%
Market Cap3.48B
Analysts51.43
Price Target43.04 (20.46%)
Short Float %2.22%
Short Ratio3.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.92% |
Yearly Dividend0.64
Dividend Growth(5Y)8.19%
DP22.04%
Div Incr Years12
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.63%
Min EPS beat(2)-0.86%
Max EPS beat(2)22.13%
EPS beat(4)3
Avg EPS beat(4)25.43%
Min EPS beat(4)-0.86%
Max EPS beat(4)47.04%
EPS beat(8)5
Avg EPS beat(8)14.68%
EPS beat(12)7
Avg EPS beat(12)14.67%
EPS beat(16)10
Avg EPS beat(16)14.19%
Revenue beat(2)2
Avg Revenue beat(2)6.93%
Min Revenue beat(2)1.91%
Max Revenue beat(2)11.94%
Revenue beat(4)4
Avg Revenue beat(4)12.03%
Min Revenue beat(4)1.91%
Max Revenue beat(4)19.67%
Revenue beat(8)8
Avg Revenue beat(8)13.53%
Revenue beat(12)11
Avg Revenue beat(12)9.96%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.94%
PT rev (3m)-3.21%
EPS NQ rev (1m)-2.96%
EPS NQ rev (3m)-4.55%
EPS NY rev (1m)-0.42%
EPS NY rev (3m)-1.06%
Revenue NQ rev (1m)-0.9%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.76 | ||
| Fwd PE | 8.3 | ||
| P/S | 0.8 | ||
| P/FCF | 5.19 | ||
| P/OCF | 5.19 | ||
| P/B | 1.37 | ||
| P/tB | 1.37 | ||
| EV/EBITDA | N/A |
EPS(TTM)4.08
EY11.42%
EPS(NY)4.3
Fwd EY12.04%
FCF(TTM)6.88
FCFY19.27%
OCF(TTM)6.88
OCFY19.27%
SpS44.88
BVpS26.01
TBVpS26.01
PEG (NY)N/A
PEG (5Y)0.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.82% | ||
| ROE | 12.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 15.63% | ||
| PM (TTM) | 6.99% | ||
| GM | N/A | ||
| FCFM | 15.34% |
ROA(3y)1.25%
ROA(5y)1.24%
ROE(3y)21.43%
ROE(5y)16.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.15%
ROCE(5y)1.99%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.08%
OM growth 5Y9.46%
PM growth 3Y-13.73%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.74 | ||
| Debt/FCF | 6.57 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 219.32% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)148.25%
Profit Quality(5y)158.67%
High Growth Momentum
Growth
EPS 1Y (TTM)12.4%
EPS 3Y12.53%
EPS 5Y16.49%
EPS Q2Q%-17.14%
EPS Next Y-4.54%
EPS Next 2Y3.85%
EPS Next 3Y5.87%
EPS Next 5Y6.59%
Revenue 1Y (TTM)7.33%
Revenue growth 3Y3.34%
Revenue growth 5Y2.35%
Sales Q2Q%5.4%
Revenue Next Year3.4%
Revenue Next 2Y3.3%
Revenue Next 3Y3.23%
Revenue Next 5Y3.66%
EBIT growth 1Y-10.56%
EBIT growth 3Y0.16%
EBIT growth 5Y12.04%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.59%
FCF growth 3Y1.61%
FCF growth 5Y-2.06%
OCF growth 1Y28.59%
OCF growth 3Y1.61%
OCF growth 5Y-2.06%